Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version

2016 ◽  
Vol 103 (6) ◽  
pp. 686-692 ◽  
Author(s):  
Yasufumi Masaki ◽  
Hiroshi Kawabata ◽  
Kazue Takai ◽  
Masaru Kojima ◽  
Norifumi Tsukamoto ◽  
...  
Keyword(s):  
Diagnostic Criteria ◽  
Disease Severity ◽  
Treatment Strategy ◽  
Tafro Syndrome ◽  
Severity Classification ◽  
Classification And Treatment

2019 Updated diagnostic criteria and disease severity classification for TAFRO syndrome

2019 ◽  
Vol 111 (1) ◽  
pp. 155-158 ◽  
Author(s):  
Yasufumi Masaki ◽  
◽  
Hiroshi Kawabata ◽  
Kazue Takai ◽  
Norifumi Tsukamoto ◽  
...  
Keyword(s):  
Diagnostic Criteria ◽  
Disease Severity ◽  
Tafro Syndrome ◽  
Severity Classification

Tentative diagnostic criteria and disease severity classification for Castleman disease: A report of the research group on Castleman disease in Japan

2017 ◽  
Vol 28 (1) ◽  
pp. 161-167 ◽  
Author(s):  
Shino Fujimoto ◽  
Tomohiro Koga ◽  
Atsushi Kawakami ◽  
Hiroshi Kawabata ◽  
Shinichiro Okamoto ◽  
...  
Keyword(s):  
Diagnostic Criteria ◽  
Disease Severity ◽  
Research Group ◽  
Castleman Disease ◽  
Severity Classification

Validation of the Japanese disease severity classification and the GAP model in Japanese patients with idiopathic pulmonary fibrosis

2016 ◽  
Vol 54 (5) ◽  
pp. 327-333 ◽  
Author(s):  
Shun Kondoh ◽  
Hirofumi Chiba ◽  
Hirotaka Nishikiori ◽  
Yasuaki Umeda ◽  
Koji Kuronuma ◽  
...  
Keyword(s):  
Idiopathic Pulmonary Fibrosis ◽  
Pulmonary Fibrosis ◽  
Disease Severity ◽  
Japanese Patients ◽  
Gap Model ◽  
Severity Classification

Diagnostic criteria, severity classification and guidelines of lichen sclerosus et atrophicus

2017 ◽  
Vol 45 (8) ◽  
pp. 891-897 ◽  
Author(s):  
Minoru Hasegawa ◽  
Osamu Ishikawa ◽  
Yoshihide Asano ◽  
Shinichi Sato ◽  
Masatoshi Jinnin ◽  
...  
Keyword(s):  
Diagnostic Criteria ◽  
Lichen Sclerosus ◽  
Lichen Sclerosus Et Atrophicus ◽  
Severity Classification

Clinical classification and treatment strategy of hamate hook fracture

2010 ◽  
Vol 30 (6) ◽  
pp. 762-766 ◽  
Author(s):  
Ge Xiong ◽  
Lufei Dai ◽  
Wei Zheng ◽  
Yankun Sun ◽  
Guanglei Tian
Keyword(s):  
Treatment Strategy ◽  
Clinical Classification ◽  
Hamate Hook Fracture ◽  
Classification And Treatment

Diagnostic criteria, severity classification and guidelines of systemic sclerosis

2018 ◽  
Vol 45 (6) ◽  
pp. 633-691 ◽  
Author(s):  
Yoshihide Asano ◽  
Masatoshi Jinnin ◽  
Yasushi Kawaguchi ◽  
Masataka Kuwana ◽  
Daisuke Goto ◽  
...  
Keyword(s):  
Systemic Sclerosis ◽  
Diagnostic Criteria ◽  
Severity Classification

Oxford Textbook of Axial Spondyloarthritis

2016 ◽  
Keyword(s):  
Back Pain ◽  
Clinical Practice ◽  
Ankylosing Spondylitis ◽  
Diagnostic Criteria ◽  
Inflammatory Disease ◽  
Axial Spondyloarthritis ◽  
Global Perspective ◽  
Main Symptom ◽  
Recent Advances ◽  
Classification And Treatment

Axial spondyloarthritis is a relatively new term, now becoming widely accepted in clinical practice, referring to inflammatory disease predominantly of the spine where the main symptom is back pain. The most common subset of AxSpA is ankylosing spondylitis. This is a rapidly evolving field with new diagnostic criteria and treatments, which are likely to evolve further. This book covers the significant recent advances in the epidemiology, genetics, pathogenesis, classification, and treatment of this disabling disease, from a truly global perspective.

scholarly journals Value Assessment of Atypical Central Neurocytoma Classification and Treatment Options

2021 ◽  
Author(s):  
Zuocheng Yang ◽  
Changxiang Yan ◽  
Zuozhen Yang ◽  
Song Han
Keyword(s):  
Treatment Strategy ◽  
Perioperative Complications ◽  
Postoperative Radiotherapy ◽  
Complete Resection ◽  
Therapeutic Modality ◽  
Incomplete Resection ◽  
Potential Candidate ◽  
Value Assessment ◽  
Resection Group ◽  
Classification And Treatment

Abstract Background The classification and treatment strategy of atypical central neurocytomas (CNs) are still controversial largely, this study aimed to explore the optical treatment strategy and characteristics in transcriptomic profile. Methods This study retrospectively analyzed data from Sixty-one patients with CNs who underwent surgery in single institution. Whole-transcriptome analysis was used to investigate the differences between typical and atypical CNs. Results The five-year OS (P= 0.015) and PFS rates (P= 0.000002) were significantly higher in the complete resection group than in the incomplete resection group. Postoperative radiotherapy did not affect OS (P=0.255) or PFS (P=0.398) in the complete resection group. The five-year PFS rate (P=0.000038) among patients in the complete resection group who did not receive radiotherapy was significantly longer than that among patients in the incomplete resection group who received radiotherapy. The extent of surgical resection and operative approaches were irrelevant to perioperative complications and dsyfunctions at the last follow-up. Compared with caudate control, some of differentially expressed genes may involve cancer. Finally, the overexpression of ten genes (AMOTL1, PIK3R3, TGFBR1, SMO, COL4A6, MGP, SOX4, IGF2, Slit1 and CKS2) in atypical CNs may be associated with malignancy in atypical CNs. Conclusion Complete resection is relatively the best therapeutic modality for atypical CNs, radiotherapy is not necessary for patients after complete resection of the tumor. Although the previous definition of atypical CNs may not have significant prognostic value, the overexpression of ten genes may be involved in malignant behaviors and potential candidate hallmarks for differentiating the atypical CNs. Although the number of cases was relatively small, the findings could be helpful and instructive in the clinical treatment of this disease.

Medulloblastoma

2018 ◽  
Author(s):  
Robert North ◽  
Ganesh Rao
Keyword(s):  
Diagnostic Criteria ◽  
Molecular Characterization ◽  
Survival Rates ◽  
Clinical Behavior ◽  
Pathological Classification ◽  
Clinical Scenarios ◽  
Tumor Types ◽  
Classification And Treatment ◽  
Brain Malignancy

Medulloblastoma is the most common brain malignancy in children. This chapter details the current diagnostic criteria, pathological classification, and treatment paradigms. Recent molecular characterization of medulloblastoma has revealed significant variations in clinical behavior of different tumor types. While the treatments for medulloblastoma are generally quite successful, with 5 year survival rates approaching 80%, the responsiveness of each subtype to treatment varies. The authors cover common clinical scenarios along with management pearls and key references.

Sign in / Sign up

Export Citation Format

Share Document